China Indicts GlaxoSmithKline Investigators

Prosecutors in Shanghai have charged a British detective and his American wife with illegally buying and selling personal information about Chinese citizens.

Copyright © 2014 NPR. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.

STEVE INSKEEP, HOST:

Prosecutors in Shanghai have charged a British detective and his American wife with illegally buying and selling personal information about Chinese citizens. They were working for a company that was already under scrutiny from China's government. NPR's Anthony Kuhn reports.

ANTHONY KUHN, BYLINE: Last year, someone inside British drugmaker GlaxoSmithKline alleged that the company's China office was bribing Chinese doctors and hospitals to use their medicines. GSK wanted to know who the whistleblower was, so they hired Shanghai-based investigator Peter Humphrey and his wife, Yu Yingzeng, to investigate. The two are charged with illegally obtaining phone logs, travel records and other data which they then put in a report to GSK. In an interview in jail, Humphrey told Chinese state media that he wasn't shown the actual allegations until after the investigation, and he believed them to true.

PETER HUMPHREY: (Chinese spoken).

KUHN: If I had been shown the content of the allegations as I had requested, he said, I would have refused to investigate. Chinese authorities have not linked the charges against Mr. Humphrey to their ongoing investigation into GSK. Anthony Kuhn, NPR News, Beijing.

Copyright © 2014 NPR. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to NPR. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

Support comes from: